[en] We have investigated the influence of a single oral administration of indomethacin on blood glucose, plasma free fatty acids (FFA), alpha-amino-nitrogen, insulin and glucagon concentrations in young healthy subjects. Two groups of 6 subjects were studied, the first received a standardized 500 kcal mixed meal without any previous drug administration (controls) whereas the second group received 50 mg indomethacin 2 h before ingesting an identical meal. Plasma indomethacin concentration reached its maximum (2.36 +/- 0.36 micro g/ml) 15 min after administration and declined to 0.45 +/- 0.04 micro g/ml after 2 h. Indomethacin ingestion was followed by a significant increase in blood glucose and plasma FFA reaching their maximum value at 45 min and returning to basal levels at 120 min. No simultaneous changes in plasma alpha-amino-nitrogen, insulin or glucagon levels were detected during this period. The meal was followed by a rise in blood glucose and plasma insulin as well as by a decrease in plasma FFA concentration. No significant differences were detected between the controls and the subjects receiving indomethacin. In controls, the meal was followed by a rise in plasma alpha-amino-nitrogen and a modest although significant increase in glucagon levels. In indomethacin-treated subjects, the increment of alpha-amino-nitrogen was less marked and the increase in plasma glucagon was not observed. Thus, indomethacin by itself can exert several metabolic effects; however, it does not deteriorate the blood glucose or insulin profile after a regular meal. The present work is the first to demonstrate that an inhibitor of prostaglandin synthesis inhibits the plasma glucagon rise occurring after a physiological stimulus such as a normal meal. On the basis of previous in vitro experiments, we suggest that this effect results from an inhibition of glucagon secretion by the PG synthesis inhibitor.
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Delporte, Jean-Pierre ; Université de Liège - ULiège > Département de pharmacie > Economie du médicament - Phamacie hospitalière
Lefebvre, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Jaminet, F.
Language :
English
Title :
Effect of indomethacin on the metabolic and hormonal response to a standardized breakfast in normal subjects.
Aronoff S.L., Kipnis D.M. (1978) Effects of indomethacin (INDO) on insulin secretion by tissue cultured-perifused rat islets. Diabetes 27:457.
Brodows R.G. (1978) Endogenous prostaglandins as insulin secretagogues; effects of indomethacin (INDO) on basal, glucose and arginine stimulated insulin release in man. Clin. Res. 26:677a.
Brodows R.S. (1980) Acute alterations in prostaglandin status fail to influence insulin secretion in man. Diabetes 29:9A.
Bybee D.E., Broadie T.R., Georges L.P., Fletcher J.R., Diaz M.J., O'Brien J.T. (1978) Indomethacin induced augmentation of insulin and glucagon release. Diabetes 27:470.
Cavagnini F., Di Landro A., Invitti C., Raggi U., Alessandrini P., Pinto M., Girotti G., Vigo P. (1977) Effects of acetylsalicylic acid and indomethacin on growth hormone secretion in man. Metabolism 26:193.
Chen M., Robertson R.P. (1979) Effects of prostaglandin synthesis inhibitors on human insulin secretion and carbohydrate tolerance. Prostaglandins 18:557.
Dalton C., Hope H.H. (1973) Inability of prostaglandin synthesis inhibition to affect adipose tissue lipolysis. Prostaglandins 4:641.
Dole V.P., Meinertz H. (1960) Microdetermination of long chain fatty acids in plasma and tissues. J. biol. Chem. 235:2395.
Dray F., Kouznetzova B., Harris D., Brazeau P. (1980) Role of prostaglandins on growth hormone secretion: PGE2 a physiological stimulator. Advances in prostaglandins and thromboxane research, Vol. 8 , B., Samuelsson, P. W., Ramwell, R., Paoletti, Raven Press, New York; 1321.
Fain J.N., Psychoyas S., Czernik A.J., Frost S., Cash W.D. (1973) Indomethacin, lipolysis and cyclic AMP accumulation in white fat cells. Endocrinology 93:632.
Ganguli S., Sperling M.A., Frame C., Christensen R. (1979) Inhibition of glucagon-induced hepatic glucose production by indomethacin. Amer. J. Physiol. 236:E 358.
Gerich J.E., Lorenzi M., Karam J.H., Schneider V., Forsham P.H. (1975) Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. J. Amer. med. Ass. 234:159.
Giugliano D., Torella R., Siniscalchi N., Improta L., D'Onofrio F. (1978) The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Diabetologia 14:359.
Hales C.N., Randle P.J. (1963) Immunoassay of insulin with insulin-antibody precipitate. Biochem. J. 88:137.
Holt L.P.J., Hawkins C.F. (1965) Indomethacin: studies of absorption and of the use of indomethacin suppositories. Brit. med. J. 1:1354.
Hvidberg E., Lausen H., Jansen J.A. (1972) Indomethacin: plasma concentrations and protein binding in man. Europ. J. clin. Pharmacol. 4:119.
Illiano S., Cuatrecasas P. (1971) Endogenous prostaglandins modulate lipolytic processes in adipose tissue. Nature (Lond.) 234:72.
Lefebvre P., Luyckx A.S. (1976) The breakfast tolerance test: a return to physiology. Diab. Metab. 2:15.
Lefebvre P., Luyckx A.S. (1979) Glucagon and diabetes: a reappraisal. Diabetes 16:347.
Lefebvre P., Luyckx A.S. (1979) Glucagon. Hormones in blood , C. H., Gray, V. H. T., James, 3rd ed., Academic Press, New York-London; 171.
Luyckx A.S. (1972) Immunoassays for glucagon. Glucagon: molecular physiology, clinical and therapeutic implications , P. J., Lefebvre, R. H., Unger, Pergamon Press, Oxford; 285.
Luyckx A.S., Deliege M., Jardon-Jeghers C., Lefebvre P.J. (1981) Insulin, prostaglandin E2 and glucagon release by human insuloma tissue incubated in vitro. Influence of indomethacin - Diab. Metab. 7:13.
Luyckx A.S., Lefebvre P. (1978) Possible role of endogenous prostaglandins in glucagon secretion by isolated guinea-pig islets. Diabetologia 15:411.
Luyckx A.S., Lefebvre P. (1980) Further studies on the role of prostaglandins in glucagon secretion. Current views on hypoglycemia and glucagon , D., Andreani, P. J., Lefebvre, V., Marks, Academic Press, New York-London; 47.
Luyckx A.S., Lefebvre P. (1980) Endogenous prostaglandins modulate glucagon secretion by isolated guinea-pig islets. Advances in prostaglandin and thromboxane research , B., Samuelsson, P. W., Ramwell, R., Paoletti, Raven Press, New York; 1299.
Malangeau P., Bourdon R., Nicaise A.M., Masson B. (1963) Dosage des acides aminés dans les liquides de l'organisme. Ann. Biol. clin. 21:1.
Pek S., Lands E.M., Akpan J., Hurley M. (1980) Effect of prostaglandins H2, D2, I2 and thromboxane on in vitro secretion of glucagon and insulin. Advances in prostaglandin and thromboxane research , B., Samuelsson, P. W., Ramwell, R., Paoletti, Raven Press, New York; 1295.
Pek S., Tai T.-Y., Crowther R., Fajans S.S. (1976) Glucagon release precedes insulin release in response to common secretagogues. Diabetes 25:764.
Pek S., Tai T.-Y., Elster A. (1978) Stimulatory effects of prostaglandins E-1, E-2 and F-2-alpha on glucagon and insulin release in vitro. Diabetes 27:801.
Robertson R.P., Gavareski D.J., Porte D. (1974) Inhibition of in vivo insulin secretion by prostaglandin E1. J. clin. Invest. 54:310.
Snedecor G.W. Statistical Methods, 5th ed., Iowa State University Press, Ames/Ia.; 1966.
SyvÄlahti E.K.G. (1974) The effect of indomethacin on serum growth hormone, immunoreactive insulin and blood glucose levels of young adult males. Int J Clin Pharmacol 10:111.
Tomasi V., Meringolo C., Bartolini G., Orlandi M. (1978) Biosynthesis of prostacyclin in rat liver endothelial cells and its control by prostaglandin E2. Nature (Lond.) 273:670.
Unger R.H. (1978) Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism 27:1691.
Vane J.R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (Lond.) 231:232.
.
Widström A. (1977) Influence of indomethacin on glucose-induced insulin response in normal man. Role of prostaglandin in the rapid insulin release?. Hormone metab. Res. 9:172.